Edward Thomas Ryan, D.T.M.&H., M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cholera | 118 | 2024 | 747 | 16.820 |
Why?
|
| Vibrio cholerae O1 | 52 | 2024 | 243 | 10.120 |
Why?
|
| Antibodies, Bacterial | 85 | 2024 | 1469 | 10.000 |
Why?
|
| Cholera Vaccines | 49 | 2024 | 262 | 9.750 |
Why?
|
| O Antigens | 26 | 2024 | 196 | 7.880 |
Why?
|
| Typhoid Fever | 30 | 2023 | 195 | 6.280 |
Why?
|
| Vibrio cholerae | 56 | 2023 | 793 | 5.560 |
Why?
|
| Salmonella typhi | 25 | 2023 | 199 | 5.280 |
Why?
|
| Travel | 41 | 2024 | 795 | 4.360 |
Why?
|
| Bangladesh | 79 | 2023 | 731 | 3.590 |
Why?
|
| Vaccines, Conjugate | 14 | 2024 | 328 | 3.560 |
Why?
|
| Immunoglobulin A | 51 | 2024 | 980 | 3.470 |
Why?
|
| Dysentery, Bacillary | 7 | 2024 | 74 | 3.300 |
Why?
|
| Vibrio cholerae O139 | 14 | 2023 | 54 | 3.000 |
Why?
|
| Diarrhea | 31 | 2024 | 1319 | 2.880 |
Why?
|
| Immunologic Memory | 27 | 2022 | 1359 | 2.600 |
Why?
|
| Antigens, Bacterial | 24 | 2022 | 1155 | 2.580 |
Why?
|
| Immunoglobulin M | 27 | 2024 | 1530 | 2.420 |
Why?
|
| Immunoglobulin G | 62 | 2024 | 4549 | 2.380 |
Why?
|
| Vaccination | 38 | 2024 | 3375 | 2.300 |
Why?
|
| Shigella Vaccines | 3 | 2024 | 10 | 1.940 |
Why?
|
| Immunity, Mucosal | 11 | 2020 | 482 | 1.850 |
Why?
|
| Cholera Toxin | 34 | 2024 | 559 | 1.830 |
Why?
|
| Salmonella paratyphi A | 8 | 2017 | 47 | 1.700 |
Why?
|
| Travel Medicine | 9 | 2023 | 83 | 1.650 |
Why?
|
| Paratyphoid Fever | 6 | 2016 | 34 | 1.550 |
Why?
|
| Typhoid-Paratyphoid Vaccines | 3 | 2020 | 39 | 1.490 |
Why?
|
| Bacteremia | 12 | 2015 | 979 | 1.460 |
Why?
|
| B-Lymphocytes | 26 | 2022 | 4748 | 1.380 |
Why?
|
| Shigella flexneri | 4 | 2024 | 119 | 1.360 |
Why?
|
| Shigella | 5 | 2023 | 69 | 1.330 |
Why?
|
| Immunity, Humoral | 5 | 2020 | 604 | 1.320 |
Why?
|
| Lipopolysaccharides | 22 | 2024 | 2205 | 1.280 |
Why?
|
| Communicable Disease Control | 10 | 2024 | 848 | 1.180 |
Why?
|
| Antibody-Producing Cells | 10 | 2021 | 140 | 1.080 |
Why?
|
| Endemic Diseases | 3 | 2024 | 190 | 1.010 |
Why?
|
| Feces | 20 | 2024 | 1494 | 0.990 |
Why?
|
| Blood Group Antigens | 4 | 2023 | 187 | 0.980 |
Why?
|
| Parasitic Diseases | 4 | 2021 | 76 | 0.980 |
Why?
|
| Antibody Formation | 12 | 2024 | 1397 | 0.970 |
Why?
|
| Disease Outbreaks | 15 | 2020 | 1762 | 0.960 |
Why?
|
| Shigella sonnei | 1 | 2024 | 7 | 0.960 |
Why?
|
| Salmonella Infections | 3 | 2015 | 171 | 0.950 |
Why?
|
| Vaccines, Combined | 2 | 2021 | 70 | 0.930 |
Why?
|
| Diarrhea, Infantile | 2 | 2015 | 101 | 0.930 |
Why?
|
| Escherichia coli Infections | 7 | 2018 | 523 | 0.900 |
Why?
|
| Child, Preschool | 74 | 2024 | 42209 | 0.900 |
Why?
|
| Communicable Diseases | 10 | 2018 | 879 | 0.900 |
Why?
|
| Serologic Tests | 5 | 2020 | 384 | 0.880 |
Why?
|
| Carrier State | 4 | 2021 | 525 | 0.870 |
Why?
|
| Antibodies, Viral | 16 | 2023 | 3155 | 0.850 |
Why?
|
| Bacterial Proteins | 13 | 2022 | 3842 | 0.770 |
Why?
|
| Tetanus Toxin | 3 | 2023 | 46 | 0.770 |
Why?
|
| Mucous Membrane | 5 | 2019 | 657 | 0.740 |
Why?
|
| Virus Diseases | 4 | 2021 | 719 | 0.730 |
Why?
|
| Child | 86 | 2024 | 80086 | 0.730 |
Why?
|
| Administration, Oral | 22 | 2021 | 4010 | 0.720 |
Why?
|
| Vaccines, Inactivated | 13 | 2023 | 179 | 0.720 |
Why?
|
| Salmonella | 4 | 2022 | 126 | 0.700 |
Why?
|
| Fever | 5 | 2024 | 1618 | 0.700 |
Why?
|
| Host-Pathogen Interactions | 6 | 2021 | 1454 | 0.690 |
Why?
|
| Humans | 266 | 2024 | 760437 | 0.690 |
Why?
|
| Bacterial Vaccines | 6 | 2009 | 401 | 0.680 |
Why?
|
|